172 related articles for article (PubMed ID: 19196217)
1. Levels of urinary human chorionic gonadotrophin (hCG) following conception and variability of menstrual cycle length in a cohort of women attempting to conceive.
Johnson SR; Miro F; Barrett S; Ellis JE
Curr Med Res Opin; 2009 Mar; 25(3):741-8. PubMed ID: 19196217
[TBL] [Abstract][Full Text] [Related]
2. Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles.
Lenton EA; de Kretser DM; Woodward AJ; Robertson DM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1180-90. PubMed ID: 1955499
[TBL] [Abstract][Full Text] [Related]
3. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
4. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
Jeppsson S; Rannevik G; Thorell JI
Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
[TBL] [Abstract][Full Text] [Related]
5. The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy.
Tovanabutra S; Illingworth PJ; Ledger WL; Glasier AF; Baird DT
Clin Endocrinol (Oxf); 1993 Jan; 38(1):101-7. PubMed ID: 8435877
[TBL] [Abstract][Full Text] [Related]
6. Late luteal rescue in the baboon (Papio cynocephalus).
Castracane VD; Stevens V; Knickerbocker J; Powell J; Randolph M; Gimpel T
Hum Reprod Update; 1998; 4(4):383-8. PubMed ID: 9825853
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle.
Odell WD; Griffin J
J Clin Endocrinol Metab; 1989 Sep; 69(3):528-32. PubMed ID: 2760168
[TBL] [Abstract][Full Text] [Related]
8. Delayed occurrence of an LH surge after HCG administration during ovarian stimulation with gonadotrophins: effect of LHRH treatment.
Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH
Hum Reprod; 1989 Aug; 4(6):643-6. PubMed ID: 2506219
[TBL] [Abstract][Full Text] [Related]
9. Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts.
Najmabadi S; Schliep KC; Simonsen SE; Porucznik CA; Egger MJ; Stanford JB
Paediatr Perinat Epidemiol; 2020 May; 34(3):318-327. PubMed ID: 32104920
[TBL] [Abstract][Full Text] [Related]
10. Production of human chorionic gonadotropin during the normal menstrual cycle.
Cole LA; Gutierrez JM
J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
[TBL] [Abstract][Full Text] [Related]
11. Norplant implants: the mechanism of contraceptive action.
Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
[TBL] [Abstract][Full Text] [Related]
12. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
[TBL] [Abstract][Full Text] [Related]
13. The normal menstrual cycle in women.
Mihm M; Gangooly S; Muttukrishna S
Anim Reprod Sci; 2011 Apr; 124(3-4):229-36. PubMed ID: 20869180
[TBL] [Abstract][Full Text] [Related]
14. Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle.
Messinis IE; Lolis D; Zikopoulos K; Milingos S; Kollios G; Seferiadis K; Templeton AA
Clin Endocrinol (Oxf); 1996 Feb; 44(2):169-75. PubMed ID: 8849571
[TBL] [Abstract][Full Text] [Related]
15. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
16. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
17. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
18. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
19. Luteinising hormone profiles in conception and non-conception natural cycles.
Johnson S; Schiffner J; Freundl G; Bachmann N; Gnoth C
Eur J Contracept Reprod Health Care; 2019 Apr; 24(2):140-147. PubMed ID: 30931648
[TBL] [Abstract][Full Text] [Related]
20. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
